The GLP-1 industry is currently an oligopoly ruled by two pharmaceutical giants, Novo Nordisk A/S (NYSE: NVO), maker of semaglutide under the Ozempic and Wegovy name brands, and Eli Lilly & Co. (NYSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results